Rituximab is associated with an increased risk of malaria among adult lymphoma patients in Malawi: a prospective observational cohort
This study was funded by the United States National Institutes of Health (K01TW011470, U54CA254564, U54CA190152, and K24AI134990).
Authors
- Stephen Kimani (ORCID: https://orcid.org/0000-0003-0403-1296)
- Maria Chikasema
- Matthew Painschab (ORCID: https://orcid.org/0000-0001-9175-7436)
- Yuri D. Fedoriw (ORCID: https://orcid.org/0000-0002-2135-2908)
- Catherine S. Forconi (ORCID: https://orcid.org/0000-0001-7358-5546)
- Luke Eastburg (ORCID: https://orcid.org/0000-0001-6123-5848)
- Ann M. Moormann (ORCID: https://orcid.org/0000-0003-1113-2829)
- Jonathan J. Juliano (ORCID: https://orcid.org/0000-0002-0591-0850)
- Oksana Kharabora
- Coxcilly Kampani
- Edwards Kasonkanji (ORCID: https://orcid.org/0000-0002-1543-814X)
- Satish Gopal (ORCID: https://orcid.org/0000-0003-2314-0316)
- Sophia Maharry Roush (ORCID: https://orcid.org/0000-0001-8686-1570)
- Dominic T. Moore
- Sneha Ashish Makhijani (ORCID: https://orcid.org/0009-0005-2173-8658)
Institutions
- University of North Carolina at Chapel Hill (US)
- University of Malawi (MW)
- University of Massachusetts Chan Medical School (US)
- National Cancer Institute (US)
- UNC Lineberger Comprehensive Cancer Center
Publication Details
- Journal
- EClinicalMedicine
- Published
- 2025-11-20
- DOI
- https://doi.org/10.1016/j.eclinm.2025.103597
- Citations
- 1
- Primary Topic
- Malaria Research and Control
- Type
- article
- Field-Weighted Citation Impact
- 1.88